An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients (DERM)

Universitaire Ziekenhuizen KU Leuven

Status: Completed

Conditions: Psoriasis

Treatments: Drug: etanercept

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02322580

S56818

Details and patient eligibility

About

The purpose of this study is to investigate the association between trough serum levels of etanercept, antibodies towards etanercept and its effectiveness in psoriasis patients.

Enrollment: 56 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Age from 18 years on, male or female
• Established diagnosis of psoriasis
• Etanercept either on monotherapy or in combination with acitretin (Neotigason®), given according to the current EU SmPC including the safety measures.
• Patients who give informed consent for this study

Trial design

56 participants in 1 patient group

Psoriasis patients who receive Enbrel® therapy

Treatment:

Drug: etanercept